VSTM
Verastem, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.44
−1.46%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.44
- Revenue estimate
- $29.3M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.35
- EPS estimate
- -$0.43
- Revenue actual
- $40.1M
- Revenue estimate
- $22.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -37.0%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $14
- PT range
- $8.00 – $18
- Analysts
- 7
7 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.43 | -$0.35 | Beat 18.70% | $40.1M |
| May 7, 2026 | -$0.46 | -$0.46 | In line | $18.7M |
| Mar 4, 2026 | -$0.49 | -$0.50 | Miss -2.04% | $17.5M |
| Nov 4, 2025 | -$0.51 | -$1.35 | Miss -164.71% | $11.2M |
| Aug 7, 2025 | -$0.85 | -$0.39 | Beat 54.12% | $2.1M |
| Mar 20, 2025 | -$0.81 | -$1.33 | Miss -64.20% | — |
| Aug 8, 2024 | -$1.06 | -$0.31 | Beat 70.75% | — |
| May 9, 2024 | -$1.16 | -$1.26 | Miss -8.62% | — |
| Mar 14, 2024 | -$0.82 | -$1.02 | Miss -24.39% | $114.0K |
| Mar 14, 2023 | $0.10 | -$0.96 | Miss -1060.00% | $2.6M |
| Nov 3, 2022 | -$1.44 | -$1.08 | Beat 25.00% | — |
| Nov 4, 2021 | -$1.08 | -$1.56 | Miss -44.44% | $2.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026